Business

At Illumina, the faster we can innovate, the more lives we can help save.  As a genomics pioneer, we have proven through focused and continued innovation how unlocking the power of the genome can exponentially improve the human condition. Our ability to drive patient outcomes has made us a trusted partner in healthcare. Today, we’re providing tools that enable the next generation of researchers and clinicians to usher in the future of personalized medicine. Innovating at the intersection of technology, biology, and health, we are re-imagining what’s possible for clinicians, transforming how they detect, diagnose, and treat cancer, and rare, infectious, and genetic diseases.

Videos from this campaign

Illumina at Dream Big
Illumina and Minderoo Foundation.

Content from this campaign

Sustainable Finance & Socially Responsible Investment

Sequencing at Sea – Unlocking the Power of the Genome With eDNA and NextSeq™ 2000
In 2022, Illumina and Minderoo Foundation announced a $40M AUD partnership to leverage the power of genomics to accelerate scientific understanding of marine systems and help marine conservationists make informed decisions.

Responsible Business & Employee Engagement

Illumina Rings the Bell at Nasdaq
The Nasdaq closing bell in New York City signifies the end of a full day of trading on the stock market, a day of transactions made to benefit shareholders and companies, and propel business forward. Fittingly, Illumina representatives rang the closing bell on March 30.

Responsible Business & Employee Engagement

25 Greatest Impacts in 25 Years: Illumina and the Evolution of Genomics
This month, Illumina celebrates a quarter century of innovation, research, and passion. As a genomics pioneer founded in San Diego in 1998, we have proven—and continue to prove—how unlocking the power of the genome can exponentially improve the human condition.

Health & Healthcare

Using Whole-Genome Sequencing To Study Early-Onset Parkinson’s Disease
The Norwegian term for virgin snow, “nysnø”, seemed the appropriate inspiration to name Jennifer Johnston’s company, NysnoBio, as it underscores the pioneering work NysnoBio is doing to tap the potential of Parkin, the protein most often linked to young onset genetic Parkinson’s

Health & Healthcare

A New Era for Discoveries at Admera Health
What role does RNA play in regulating fat deposits? Which transcription factors affect insulin resistance and halt cancer progression? What is the viral load in one country’s estuarine and coastal waters? Researchers posing such questions turn to Admera Health.

Innovation & Technology

RNA Sequencing Critical to Identifying Key Fusions for Oncology Patients
At the Phoenix Convention Center in Arizona, representatives from Illumina, a global leader in DNA sequencing and array-based technologies, joined approximately 2000 molecular diagnostic professionals this month for the Association for Molecular Pathology (AMP) 2022 Annual Meeting & Expo.

Events, Media & Communications

Illumina To Host Second Annual Virtual ESG Investor Event on Friday, October 28, 2022
Illumina announced that it will host its second annual virtual Environment, Social and Corporate Governance (ESG) focused investor event at 9:30 am Pacific Time (12:30 pm Eastern Time), Friday, October 28, 2022.

Innovation & Technology

Illumina Introduces Multiple Breakthrough Sequencing Innovations at Inaugural Genomics Forum
Illumina, a global leader in DNA sequencing and array-based technologies, today announced multiple breakthrough sequencing innovations at its inaugural Illumina Genomics Forum:

Innovation & Technology

Illumina Unveils Revolutionary NovaSeq X Series To Rapidly Accelerate Genomic Discoveries and Improve Human Health
llumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the launch of the NovaSeq™ X Series

Health & Healthcare

Latest Research at ESMO Congress 2022 Showcases the Impact of Comprehensive Genomic Profiling for Cancer Patients
Illumina a global leader in DNA sequencing and array-based technologies, announced the upcoming presentation of multiple oncology research abstracts at this year’s European Society of Medical Oncology (ESMO) annual meeting, September 9–13 in Paris.
Illumina logo

More from Illumina

  1. People
    Harnessing the world’s best talent and giving them the opportunity to thrive allows us to make world-changing leaps in human health and beyond. Our...

  2. Access
    Genomics should be available to the many, not the few. It has the power to save lives and vastly improve the human condition. As the leader in...

  3. Business
    At Illumina, the faster we can innovate, the more lives we can help save. As a genomics pioneer, we have proven through focused and continued...

  4. Environment
    We are committed to integrating environmental stewardship into the way we operate. We recognize the importance of the environment in creating a...

  5. Community
    By sharing our time, talent, and technology, we aim to inspire, support, and empower our communities, our employees, and the next generation.

  6. Operating Responsibly
    Our role as a genomics pioneer brings with it the responsibility to enable innovation for good, ensuring that the technology we create and the data we...